Extensively Drug-Resistant Tuberculosis - 16 Studies Found
| Completed |
: Linezolid Pharmacokinetics (PK) in Multi-Drug Resistant (MDR)/Extensively-Drug Resistant (XDR) Tuberculosis (TB) :
|
| Completed |
: Drug Interaction Study Between Linezolid and Clarithromycin in Tuberculosis Patients :
|
| Completed |
: Linezolid to Treat Extensively-Drug Resistant Tuberculosis :
|
| Not yet recruiting |
: Safety and Efficacy of Various Doses and Treatment Durations of Linezolid Plus Bedaquiline and Pretomanid in Participants With Pulmonary TB, XDR-TB, Pre- XDR-TB or Non-responsive/Intolerant MDR-TB (ZeNiX) :
|
| Completed |
: TBTC Study 30: Safety and Tolerability of Low Dose Linezolid in MDR TB :
|
| Completed |
: An Open-label RCT to Evaluate a New Treatment Regimen for Patients With Multi-drug Resistant Tuberculosis :
|
| Completed |
: Tuberculosis in China :
|
| Completed |
: Pragmatic Clinical Trial for a More Effective Concise and Less Toxic MDR-TB Treatment Regimen(s) :
|
| Completed |
: A Placebo-controlled, Phase 2 Trial to Evaluate OPC 67683 in Patients With Pulmonary Sputum Culture-positive, Multidrug-resistant Tuberculosis (TB) :
|
| Completed |
: A Phase 3 Study Assessing the Safety and Efficacy of Bedaquiline Plus PA-824 Plus Linezolid in Subjects With Drug Resistant Pulmonary Tuberculosis : Pulmonary Tuberculosis : 2015-01-06 :
|